129 - Why Corporate VCs in Healthcare Might Be Your Startup’s Secret Weapon w/ Doba Parushev

In this episode, Vic and Marcus sit down with Doba Parushev, Managing Partner at Healthworx, to unpack the distinct differences between traditional and corporate venture capital, particularly within healthcare. Doba shares his career journey from engineering to Latin American VC, through McKinsey and Edison Partners, to leading Healthworx at CareFirst. The conversation covers the pros and cons of corporate VCs for startups, the expectations versus realities of these partnerships, how investment strategies are shaped by member needs, and Healthworx’s multi-pronged investment approach including its ventures, accelerator, studio, and LP programs. They also explore systemic inefficiencies in U.S. healthcare, the value of tech-enabled services, and how Healthworx balances financial returns with strategic impact. Doba closes with hard-won advice for both startups and enterprises considering corporate venture capital.
Doba Parushev - https://www.linkedin.com/in/parushev/
Healthworx Website - https://www.healthworx.com/
HF Site (https://jumpstarthealth.co/health-further-podcast/)

YOUTUBE (https://tinyurl.com/448vzvc3)
INSTAGRAM (https://tinyurl.com/y3k43rh2)
TWITTER (https://tinyurl.com/yeyxkz34)
FACEBOOK (https://tinyurl.com/krm37s9k)
LINKEDIN (https://tinyurl.com/3feznutb)
TIKTOK (https://tinyurl.com/2xnb4r6m)

Видео 129 - Why Corporate VCs in Healthcare Might Be Your Startup’s Secret Weapon w/ Doba Parushev канала Health:Further